Showing results (791-800 of 1,842) with videos related to
Sort By:
Pageof 185
Journal of Managed Care & Specialty Pharmacy|October 29, 2024
Dose escalation of biologics in biologic-naive patients with Crohn's disease: Outcomes from the ODESSA-CD studyNoa Krugliak Cleveland, Sabyasachi Ghosh, Niranjan Kathe, et al.Journal of Managed Care & Specialty Pharmacy|October 29, 2024
Unlocking the potential of digital therapeutics: The need for consistent and granular inclusion in drug compendia for managed careAnn Johnson, Rick Bartels, Joe Honcz, et al.Journal of Managed Care & Specialty Pharmacy|October 29, 2024
Impact of discontinuing disease-modifying therapies on health care utilization among midlife patients with multiple sclerosis in the United StatesYiran Qian, Carolyn T Thorpe, Casey Tak, et al.Journal of Managed Care & Specialty Pharmacy|November 29, 2024
Antidepressant therapeutic strategies and health care utilization in patients with depressionPhuong Tran, Susan dosReis, Eberechukwu Onukwugha, et al.Journal of Managed Care & Specialty Pharmacy|November 29, 2024
Area deprivation index impact on type 2 diabetes outcomes in a regional health planTaylor N Laffey, David Marr, Ashley Modany, et al.Journal of Managed Care & Specialty Pharmacy|November 29, 2024
Concentration of spending and share of specialty drug spending in Medicare Part D over a 10-year periodShu Niu, Laura E Happe, Sumaya Abuloha, et al.Journal of Managed Care & Specialty Pharmacy|November 29, 2024
Health care costs among patients with relapsed/refractory multiple myeloma treated with ixazomib or daratumumab in combination with lenalidomide and dexamethasone in the United StatesSikander Ailawadhi, Mu Cheng, Maral DerSarkissian, et al.Journal of Managed Care & Specialty Pharmacy|September 11, 2024
Estimating the economic impact of blister-packaging on medication adherence and health care costs for a Medicare Advantage health planEric P Borrelli, Peter Saad, Nathan Barnes, et al.Journal of Managed Care & Specialty Pharmacy|August 1, 2024
Total cost of care of Medicare Advantage beneficiaries participating in an appointment-based model in a national pharmacy chainHeidi Luder, Josilaida Lawrence, Shirley Musich, et al.Journal of Managed Care & Specialty Pharmacy|July 24, 2024
Real-world comparison of health care costs of venetoclax-obinutuzumab vs Bruton's tyrosine kinase inhibitor use among US Medicare beneficiaries with chronic lymphocytic leukemia in the frontline settingScott F Huntington, Beenish S Manzoor, Dureshahwar Jawaid, et al.Pageof 185